Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Aligos Therapeutics (ALGS) Asset Utilization Ratio (2021 - 2025)

Aligos Therapeutics filings provide 5 years of Asset Utilization Ratio readings, the most recent being 0.02 for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio fell 72.28% to 0.02 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.02, a 72.28% decrease, with the full-year FY2025 number at 0.03, down 15.42% from a year prior.
  • Asset Utilization Ratio hit 0.02 in Q4 2025 for Aligos Therapeutics, down from 0.04 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.21 in Q3 2023 to a low of 0.02 in Q3 2022.
  • Median Asset Utilization Ratio over the past 5 years was 0.05 (2024), compared with a mean of 0.07.
  • Biggest five-year swings in Asset Utilization Ratio: surged 1159.37% in 2023 and later tumbled 76.19% in 2024.
  • Aligos Therapeutics' Asset Utilization Ratio stood at 0.02 in 2021, then skyrocketed by 506.32% to 0.11 in 2022, then plummeted by 31.7% to 0.07 in 2023, then rose by 9.82% to 0.08 in 2024, then crashed by 72.28% to 0.02 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.02 (Q4 2025), 0.04 (Q3 2025), and 0.04 (Q2 2025) per Business Quant data.